Correlation Between CRISPR Therapeutics and Ecotel Communication

Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and Ecotel Communication at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and Ecotel Communication into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CRISPR Therapeutics AG and ecotel communication ag, you can compare the effects of market volatilities on CRISPR Therapeutics and Ecotel Communication and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of Ecotel Communication. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and Ecotel Communication.

Diversification Opportunities for CRISPR Therapeutics and Ecotel Communication

0.17

Correlation Coefficient

CRISPR Therapeutics  Ecotel Communication

Average diversification

The 3 months correlation between CRISPR and Ecotel is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and ecotel communication ag in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ecotel communication and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with Ecotel Communication. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ecotel communication has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and Ecotel Communication go up and down completely randomly.

Pair Corralation between CRISPR Therapeutics and Ecotel Communication

Assuming the 90 days trading horizon CRISPR Therapeutics AG is expected to generate 2.86 times more return on investment than Ecotel Communication. However, CRISPR Therapeutics is 2.86 times more volatile than ecotel communication ag. It trades about 0.13 of its potential returns per unit of risk. ecotel communication ag is currently generating about 0.07 per unit of risk. If you would invest  4,080  in CRISPR Therapeutics AG on April 20, 2025 and sell it today you would earn a total of  1,470  from holding CRISPR Therapeutics AG or generate 36.03% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

CRISPR Therapeutics AG  vs.  ecotel communication ag

CRISPR Therapeutics

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in CRISPR Therapeutics AG are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, CRISPR Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

ecotel communication

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in ecotel communication ag are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady fundamental indicators, Ecotel Communication may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Pair Trading with CRISPR Therapeutics and Ecotel Communication

The main advantage of trading using opposite CRISPR Therapeutics and Ecotel Communication positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, Ecotel Communication can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ecotel Communication will offset losses from the drop in Ecotel Communication's long position.

The idea behind CRISPR Therapeutics AG and ecotel communication ag pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..